Hideki Takeuchi

This inventor holds 12 USPTO granted patents, plus 4 CIPO patents and 4 EPO patents. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideki Takeuchi. Retrieved from https://idiyas.com/inventor/hideki-takeuchi-56hczceq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 50.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 12(Granted Patents)

Location History:

Nagano, JP (2006 - 2009)
Joetsu, JP (2013 - 2020)

Company Filing History:

12 out of 176

Kissei Pharmaceutical Co., Ltd.

patents

Years Active: 2006-2020

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10576084 - Salt of fused heterocyclic derivative and crystal thereof (2020-03-03),

2. 10016433 - Salt of fused heterocyclic derivative and crystal thereof (2018-07-10),

3. 9737539 - Salt of fused heterocyclic derivative and crystal thereof (2017-08-22),

4. 9169266 - Salt of fused heterocyclic derivative and crystal thereof (2015-10-27),

5. 8399418 - Monosebacate of pyrazole derivative (2013-03-19),

6. 8354382 - Hemifumarate of a pyrazole derivative (2013-01-15),

7. 7589126 - 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation (2009-09-15),

8. 7579507 - Polymorphic crystal of 4'-{2-[ (1S, 2R)—2- hydroxy-2- (4-hydroxyphenyl)-1-methylethylamino]ethoxy} - 3 - isopropyl-3′, 5′ -dimethylbiphenyl- 4 - carboxylic acid hydrochloride (2009-08-25),

9. 7256215 - Crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative (2007-08-14),

10. 7217832 - 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation (2007-05-15),

11. 7208524 - 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation (2007-04-24),

12. 7022689 - 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor (2006-04-04),

Title: The Innovative Contributions of Hideki Takeuchi

Introduction

Hideki Takeuchi is a prominent inventor based in Joetsu, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work focuses on developing innovative compounds that enhance solubility and stability, which are crucial for effective drug formulation.

Latest Patents

Among his latest patents is the invention of a salt of a fused heterocyclic derivative and its crystal form. This invention provides a specific compound, 3-[2-fluoro-5-(2,3-difluoro-6-methoxybenzyl-oxy)-4-methoxyphenyl]-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid choline salt. This compound is noted for its excellent solubility and storage stability, making it a valuable addition to pharmaceutical applications.

Career Highlights

Hideki Takeuchi is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to numerous advancements that benefit both the industry and patients.

Collaborations

Throughout his career, Takeuchi has collaborated with notable colleagues, including Yuichiro Kai and Kenji Yokoyama. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Hideki Takeuchi's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to impact the field positively, paving the way for future advancements in drug development.

Profile summary based on public USPTO records.